Novel compound for treating sensitive, isoniazid resistant strains and multi drug resistant mycobacterium tuberculosis

摘要

ABSTRACT A method for separating compound (4E)-l,5-bis(4-hydroxyphenyl)-l-ethoxy-2-(meth-oxymethyl)-4-pentenes from Alpinia officinarum and composition thereof for treating Mycobacterium tuberculosis infection inclusive of avirulent H37Ra, standard virulent H37Rv strains and isoniazid resistant and multidrug resistant strains.